Institutional Ownership
Bicara Therapeutics Inc
CUSIP 055477103COMBCAXQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
12.8%
Max % of class reported
Institutional Holders
141
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Mar 2, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 2, 2026 | Ra Capital Management, L.P. | 13D/A | 11.5% | — | SEC |
| 2 | Feb 17, 2026 | T. Rowe Price Investment Management, Inc. | 13G | 5.9% | 3.24M | SEC |
| 3 | Feb 17, 2026 | Vestal Point Capital, LP | 13G/A | 6.5% | 3.58M | SEC |
| 4 | Feb 12, 2026 | Deep Track Capital, LP | 13G | 5.0% | 2.75M | SEC |
| 5 | Feb 5, 2026 | Fmr LLC | 13G/A | 6.1% | 3.35M | SEC |
| 6 | Aug 14, 2025 | Vestal Point Capital, LP | 13G/A | 9.2% | 5.00M | SEC |
| 7 | Jul 31, 2025 | Invus Public Equities, L.P. | 13G/A | 9.6% | 5.22M | SEC |
| 8 | Jul 17, 2025 | Fmr LLC | 13G | 5.1% | 2.76M | SEC |
| 9 | Jul 17, 2025 | Fmr LLC | 13G/A | 4.7% | 2.54M | SEC |
| 10 | May 15, 2025 | Vestal Point Capital, LP | 13G | 5.1% | 2.77M | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Bicara Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 7.26M | $144.32M |
| 2 | Siren, L.L.C. | 5.80M | $115.42M |
| 3 | Vestal Point Capital, LP | 5.42M | $107.90M |
| 4 | Deep Track Capital, LP | 4.06M | $80.80M |
| 5 | Janus Henderson Group PLC | 3.34M | $66.35M |
| 6 | Red Tree Management, LLC | 3.17M | $63.06M |
| 7 | Tpg Gp A, LLC | 3.01M | $59.88M |
| 8 | Blackrock, Inc. | 2.84M | $56.56M |
| 9 | Omega Fund Management, LLC | 2.39M | $47.58M |
| 10 | Royalty Pharma Sub-Manager, LLC | 2.39M | $46.69M |